[ET Net News Agency, 3 May 2023] Credit Suisse raised its target price for Sinopharm
Group (01099) to HK$29 from HK$26 and downgraded its rating to "neutral" from
"outperform".
The research house said it lifts FY23/24/25E EPS by 0.4%/4.2%/5.0%, as it slightly cuts
the near-term GPM but adjusts operating expense, finance costs, and other gains based on
the 1Q23 results. (RC)